Detalles de la búsqueda
1.
CDK4/6-Inhibitors Versus Chemotherapy in Advanced HR+/HER2-Negative Breast Cancer: Results and Correlative Biomarker Analyses of the KENDO Randomized Phase II Trial.
Oncologist
; 29(5): e622-e634, 2024 May 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-38175669
2.
Computed tomography based analyses of body mass composition in HER2 positive metastatic breast cancer patients undergoing first line treatment with pertuzumab and trastuzumab.
Sci Rep
; 12(1): 3385, 2022 03 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35233007
3.
Ki67 and PR in Patients Treated with CDK4/6 Inhibitors: A Real-World Experience.
Diagnostics (Basel)
; 10(8)2020 Aug 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-32784518
Resultados
1 -
3
de 3
1
Próxima >
>>